The hospital medicine track is new to the program as of the 2020-2021 academic year, with the first class of residents having been selected in May 2020. The track will accept 3-5 residents each year.
CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...